A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy




TekijätJokela M., Tasca G., Vihola A., Mercuri E., Jonson P., Lehtinen S., Välipakka S., Pane M., Donati M., Johari M., Savarese M., Huovinen S., Isohanni P., Palmio J., Hartikainen P., Udd B.

Julkaisuvuosi2019

JournalNeurology

Tietokannassa oleva lehden nimiNeurology

Vuosikerta92

Numero14

AloitussivuE1600

LopetussivuE1609

ISSN1526-632X

eISSN1526-632X

DOIhttps://doi.org/10.1212/WNL.0000000000007246

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/40494259


Tiivistelmä

Objective To identify the genetic defect causing a distal calf myopathy with cores.

Methods Families with a genetically undetermined calf-predominant myopathy underwent detailed clinical evaluation, including EMG/nerve conduction studies, muscle biopsy, laboratory investigations, and muscle MRI. Next-generation sequencing and targeted Sanger sequencing were used to identify the causative genetic defect in each family.

Results A novel deletion-insertion mutation in ryanodine receptor 1 (RYR1) was found in the proband of the index family and segregated with the disease in 6 affected relatives. Subsequently, we found 2 more families with a similar calf-predominant myopathy segregating with unique RYR1-mutated alleles. All patients showed a very slowly progressive myopathy without episodes of malignant hyperthermia or rhabdomyolysis. Muscle biopsy showed cores or core-like changes in all families.

Conclusions Our findings expand the spectrum of RYR1-related disorders to include a calf-predominant myopathy with core pathology and autosomal dominant inheritance. Two families had unique and previously unreported RYR1 mutations, while affected persons in the third family carried 2 previously known mutations in the same dominant allele.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 12:08